Evidence map›Paper›PMID 36831516›Full record

ReviewCancers2023

Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).

Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, Isabel Rubio, Jana de Boniface, Nina Ditsch, Güldeniz Karadeniz Cakmak, Andreas Karakatsanis, Rajiv Dave, Markus Hahn and 18 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05559411 (A Prospective Non-interventional Multicenter Cohort Study to Evaluate Different Imaging-guided Methods for Localization of Non-palpable Malignant Breast Lesions), which is not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05559411 recruitingnot on this map

A Prospective Non-interventional Multicenter Cohort Study to Evaluate Different Imaging-guided Methods for Localization of Non-palpable Malignant Breast Lesions

TypeobservationalSponsorEuropean Breast Cancer Research Association of Surgical TrialistsRan2023 to 2026Enrolled7,416ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. RADar Reflector LocalisatIOn-SCOUTAnnals of surgical oncology · 2026
    Observational
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. SCOUTCancers · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Maggie Banys-PaluchowskiDepartment of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.
Thorsten KühnDepartment of Gynecology and Obstetrics, Die Filderklinik, 70794 Filderstadt, Germany.
Yazan MasannatAberdeen Breast Unit, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK.ORCID 0000-0002-5895-5059
Isabel RubioBreast Surgical Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain.ORCID 0000-0003-0035-0679
Jana de BonifaceDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 17177 Stockholm, Sweden.
Nina DitschBreast Cancer Center, University Hospital Augsburg, 86156 Augsburg, Germany.
Güldeniz Karadeniz CakmakBreast and Endocrine Unit, General Surgery Department, Zonguldak BEUN The School of Medicine, Kozlu/Zonguldak 67600, Turkey.ORCID 0000-0001-5802-4441
Andreas KarakatsanisDepartment for Surgical Sciences, Faculty of Pharmacy and Medicine, Uppsala University, 75236 Uppsala, Sweden.ORCID 0000-0003-3622-3575
Rajiv DaveNightingale & Genesis Breast Cancer Prevention Centre, Manchester University NHS Foundation Trust, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0001-6827-8090
Markus HahnDepartment for Women's Health, University of Tübingen, 72076 Tübingen, Germany.
Shelley PotterBristol Medical School (THS), Bristol Population Health Science Institute, Bristol BS8 1QU, UK.
Ashutosh KothariGuy's & St Thomas NHS Foundation Trust, Kings College, London SE1 9RT, UK.
Oreste Davide GentiliniDepartment of Breast Surgery, San Raffaele University and Research Hospital, 20132 Milan, Italy.ORCID 0000-0002-4489-1867
Bahadir M GulluogluDepartment of Surgery, Breast Surgery Unit, Marmara University School of Medicine and SENATURK Turkish Academy of Senology, Istanbul 34854, Turkey.
Michael Patrick LuxDepartment of Gynecology and Obstetrics, St. Louise Frauen-und Kinderklinik, 33098 Paderborn, Germany.ORCID 0000-0002-2781-2178
Marjolein SmidtDepartment of Surgical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
Walter Paul WeberDivision of Breast Surgery, Department of Surgery, Basel University Hospital, 4031 Basel, Switzerland.
Bilge Aktas SezenEuropean Breast Cancer Research Association of Surgical Trialists (EUBREAST), 73730 Esslingen, Germany.
Natalia KrawczykDepartment of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Steffi HartmannDepartment of Gynecology and Obstetrics, University Hospital Rostock, 18059 Rostock, Germany.ORCID 0000-0002-0145-1589
Rosa Di MiccoDepartment of Breast Surgery, San Raffaele University and Research Hospital, 20132 Milan, Italy.ORCID 0000-0002-2575-8729
Sarah NietzDepartment of Surgery, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.ORCID 0000-0002-6313-2794
Francois MalherbeBreast and Endocrine Surgery Unit, Groote Schuur Hospital, University of Cape Town, Cape Town 7935, South Africa.ORCID 0000-0001-8910-6925
Neslihan CabiogluIstanbul Faculty of Medicine, Department of General Surgery, Istanbul University, Istanbul 34093, Turkey.
Nuh Zafer CanturkDepartment of General Surgery, Kocaeli University School of Medicine, Kocaeli 41001, Turkey.
Maria Luisa GasparriDepartment of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, 6900 Lugano, Switzerland.
Dawid MurawaGeneral Surgery and Surgical Oncology Department, Collegium Medicum, University in Zielona Gora, 65-417 Zielona Góra, Poland.ORCID 0000-0003-3156-1882
James HarveyNightingale & Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester M13 9PL, UK.ORCID 0000-0002-1359-2186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical excision of a non-palpable breast lesion requires a localization step. Among available techniques, wire-guided localization (WGL) is most commonly used. Other techniques (radioactive, magnetic, radar or radiofrequency-based, and intraoperative ultrasound) have been developed in the last two decades with the aim of improving outcomes and logistics.

methodsWe performed a systematic review on localization techniques for non-palpable breast cancer.

resultsFor most techniques, oncological outcomes such as lesion identification and clear margin rate seem either comparable with or better than for WGL, but evidence is limited to small cohort studies for some of the devices. Intraoperative ultrasound is associated with significantly higher negative margin rates in meta-analyses of randomized clinical trials (RCTs). Radioactive techniques were studied in several RCTs and are non-inferior to WGL. Smaller studies show higher patient preference towards wire-free localization, but little is known about surgeons' and radiologists' attitudes towards these techniques.

conclusionsLarge studies with an additional focus on patient, surgeon, and radiologist preference are necessary. This review aims to present the rationale for the MELODY (NCT05559411) study and to enable standardization of outcome measures for future studies.

Indexed as

breast cancerintraoperative ultrasoundlocalization techniquemagnetic seednon-palpable lesionradar reflectorradioactive seedradiofrequency identification tagwire-guided localization

Identifiers

PMID36831516
PMCPMC9954476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.